secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vanda Pharmaceuticals Inc. (VNDA)
CIK:        0001347178
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001193125-24-133252
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vanda receives revised unsolicited takeover proposal from Future Pak at $7.25-$7.75/share plus CVRs
--------------------------------------------------------------------------------

- Revised proposal of $7.25-$7.75 per share in cash plus Contingent Value Rights (CVRs).
- Vanda's Board will evaluate the proposal with its financial and legal advisors.
- Prior proposal at same price range was rejected by Vanda.
- No shareholder action required at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347178/000119312524133252/0001193125-24-133252-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347178/000119312524133252/d810702d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-133252

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer